Alnylam Pharmaceuticals
ALNY
ALNY
617 hedge funds and large institutions have $34.2B invested in Alnylam Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 107 funds opening new positions, 236 increasing their positions, 197 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% more capital invested
Capital invested by funds: $30B → $34.2B (+$4.2B)
5% more funds holding
Funds holding: 585 → 617 (+32)
1.17% less ownership
Funds ownership: 98.99% → 97.81% (-1.2%)
Holders
617
Holding in Top 10
10
Calls
$274M
Puts
$238M
Top Buyers
| 1 | +$493M | |
| 2 | +$174M | |
| 3 | +$95.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$81.2M |
Top Sellers
| 1 | -$428M | |
| 2 | -$334M | |
| 3 | -$103M | |
| 4 |
BlackRock
New York
|
-$88M |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$63.7M |
